In vitro editing in mammalian nuclear extracts reveals adenosine-to-inosine conversions in glutamate receptor messenger RNAs. Current studies of the different types of RNA editing are mostly focused on identifying the cellular factors that catalyze editing in vivo. In contrast to the hardships usually encountered during the search for such factors, even at its first report in 1991 [3], the characteristics of gluR mRNA editing suggested that the enzyme responsible may already be known. Editing within gluR mRNAs occurs at sites of genomic adenosines which, after editing, appear as guanosines in cDNAs. The observed A to G transitions are consistent with the action of a previously characterized enzyme known as doublestranded RNA (dsRNA) adenosine deaminase (dsRAD).
The discovery of RNA editing, almost a decade ago, brought a new twist to the familiar tale of how genetic information flows from DNA to protein. RNA editing involves the insertion, deletion or substitution of nucleotides within nascent RNA transcripts, and produces RNA molecules with sequences that differ from those encoded genomically (reviewed in [1] ). RNA editing can alter the encoded open reading frame of a messenger (m)RNA, or produce non-encoded nucleotides required for ribosomal (r) and transfer (t) RNAs to fold into their correct native structures. Most examples of RNA editing have been found in organelle-encoded RNAs, and the large number of these examples has made researchers studying organelle processes cautious in assuming that a cDNA sequence corresponds to that of its gene. Researchers studying nuclear-encoded RNAs have not adopted this cautious approach, because few examples of edited nuclear-encoded RNAs have'been reported. The nuclear-encoded RNAs for which editing has been observed are all mammalian and include apolipoprotein B mRNA, several glutamate receptor (gluR) mRNAs and the Wilms' tumor susceptibility gene mRNA (see [2] and references cited in [1] ).
Current studies of the different types of RNA editing are mostly focused on identifying the cellular factors that catalyze editing in vivo. In contrast to the hardships usually encountered during the search for such factors, even at its first report in 1991 [3] , the characteristics of gluR mRNA editing suggested that the enzyme responsible may already be known. Editing within gluR mRNAs occurs at sites of genomic adenosines which, after editing, appear as guanosines in cDNAs. The observed A to G transitions are consistent with the action of a previously characterized enzyme known as doublestranded RNA (dsRNA) adenosine deaminase (dsRAD).
The enzyme dsRAD deaminates adenosines within dsRNA to produce inosines and was discovered rather serendipitously in 1987, when a synthetic dsRNA was injected into the cytoplasm of Xenopus embryos (see citations in [1] ). As inosine, like guanosine, prefers to pair with cytidine, inosines within an RNA appear as guanosines in cDNAs, as observed for the gluR mRNAs. Over the years, dsRAD activity has been detected in organisms throughout the animal kingdom, including mammals, but it has remained an enzyme in search of a function.
The RNA transcripts for several different gluR subunits are edited, and multiple editing sites can occur within a single gluR mRNA [4, 5] . Although not all of the editing events appear to be functionally relevant, some produce codon changes that clearly alter the properties of the ion channels assembled from the gluR subunits. One of the functionally important editing sites -the Q/R siteconverts a glutamine (Q) codon to an arginine (R) codon within mRNAs encoding subunits B, 5 and 6 [3, 5] , while another -the R/G site -converts an arginine (R) to a glycine (G) within mRNAs for subunits B, C and D [6] .
Further support for a role for dsRAD in gluR mRNA editing came in 1993, when Seeburg and colleagues [5] showed editing at the Q/R site of gluR-B RNA requires base-pairing between the surrounding exon sequences and the downstream intron. The unspliced RNA is predicted to form a double-stranded structure, periodically interrupted by internal loops, mismatches and bulges (see Fig. 1 ). More recently, Seeburg's laboratory [6] identified the R/G site mentioned above and showed that this editing event is also dependent on a structure that is largely double-stranded.
Three recent reports [7] [8] [9] provide further evidence for the involvement of dsRAD in gluR RNA editing. These reports, one a collaborative effort by the laboratories of Tom Maniatis and Richard Axel [7] , another by Ron Emeson and colleagues [8] , and the third a collaboration between the laboratories of Walter Keller and Peter Seeburg [9] , all demonstrate that gluR transcripts synthesized in vitro can be correctly edited when incubated with mammalian nuclear extracts. Most importantly, all three groups present clear evidence that editing in vitro involves the conversion of adenosines to inosines. Consistent with the characteristics of dsRAD determined in vitro with synthetic substrates (see citations in [1] ), editing of gluR RNA in these in vitro systems does not require the addition of cofactors, is sensitive to proteinase K and requires the dsRNA structure predicted to surround the editing sites.
All three groups show that in vitro editing of gluR RNA can be competed with various dsRNAs, as expected if dsRAD is responsible for the editing. Two of the reports [7, 8] also show that gluR-B RNA competes for its own editing better than a synthetic dsRNA designed to form a completely base-paired structure. This latter result should be treated cautiously, as it is not clear if the various dsRNA competitors have the same number of binding sites for the editing enzyme, whether the substrate inhibition characteristic of dsRAD is operating [10] , or just how many other dsRNA-binding proteins exist in Fig. 1 . A hypothetical structure encompassing the Q/R site, and showing additional editing sites mapped within endogenous rat [8] and mouse [5] glutamate receptor RNAs. The height of the green bars is relative to the number of rat cDNAs that contained a particular A to G transition, with sites represented in s 10% of the population indicated with green asterisks and exact percentages indicated for editing hot spots. Only editing hot spots are shown for the mouse sequence (red dots). Blue letters indicate nucleotides encoded by the mouse gene that differ from those of the rat (as detailed in [8] ). The secondary structure has not been confirmed, but the helices shown are supported by compensatory mutations at all nucleotides paired with an orange line (see [5, 7, 8] ). Little information is available regarding the structure of the sequences shown as unpaired (surrounding the question mark). All editing sites shown are in intron sequences except for the Q/R site and the adjacent site, the editing of which results in a silent codon change.
the crude extracts. These cautions aside, however, an interesting interpretation of these data is that dsRAD has a particular high affinity for the native, intramolecular gluR-B RNA structure.
The paper by Yang et al. [7] also reports that the sites of in vitro editing in gluR-B RNA are different from those found in a completely base-paired substrate formed by hybridizing gluR-B RNA to an antisense transcript. Taken together, these observations are reminiscent of early studies of the bacterial dsRNA nuclease, RNase III. Like dsRAD, RNase III was discovered by its action on dsRNA and initially characterized using completely base-paired dsRNA [11] . Once the biological substrates of RNase III were discovered, it became very clear that the enzyme is sensitive to various structural elements not present in the dsRNAs used in its initial characterization (reviewed in [12] ).
Although the three papers report similar observations, they each also offer distinct insights. For example, while all the papers demonstrate in vitro editing at the Q/R site, the one by Melcher et al. [9] also shows that the R/G site can be edited in vitro. The paper by Rueter et al. [8] is notable for its demonstration (by cDNA sequencing) that RNAs edited in vitro, like their endogenous counterparts, are edited at multiple sites within the proposed doublestranded regions (see Fig. 1 ). The observed patterns of editing look very much like those catalyzed by dsRAD in vitro on synthetic substrates [13] . Editing hot spots are observed, and the editing sites occur at adenosines known to be preferred by dsRAD. For example, consistent with the 5' nearest-neighbor preference of dsRAD -A = U > C > G -none of the editing hot spots, and only one of the minor sites, has a 5' guanosine.
Rueter et al. [8] mapped a total of 14 editing sites within endogenous RNA isolated from rat brain, and found that in vitro edited transcripts are edited at fewer sites overall, but the edited sites are a subset of those found in vivo. The in vitro edited RNAs are reminiscent of the intermediates observed in the reaction of dsRAD with synthetic substrates, and it seems possible that RNAs edited in vitro were exposed to less dsRAD, or for shorter lengths of time, than those edited in vivo. Interestingly, Melcher et al. [9] mention that only the Q/R and R/G sites were edited in their in vitro system; this may indicate there were lower levels of dsRAD in the extracts used by these researchers.
Although dsRAD is clearly present in the crude extracts used by all three groups, the rigorous individual will note that dsRAD has not been directly demonstrated to be the enzyme responsible for the editing, and further, that inosine has not yet been shown to be present within endogenous gluR mRNA. However, given the similarities between the requirements for gluR RNA editing and the properties of dsRAD characterized in vitro, it is very hard to argue that dsRAD is not involved in gluR RNA editing. In this light, the most important question at present is not whether dsRAD is involved in this editing event, but whether it acts alone in vivo, or with accessory factors.
The paper by Yang et al. [7] directly addresses this question. These authors biochemically fractionated the crude nuclear extract they were using on a dsRNA affinity column, and found that a fraction enriched in gluR--B RNA editing activity eluted at a higher salt concentration than the fraction containing the bulk of dsRAD. Perhaps this fraction contains an alternative form of dsRAD, with different editing and chromatographic properties. Alternatively, the fraction may contain dsRAD as well as a second factor, or factors, that interact with dsRAD. Greater than 3M salt is required to elute the gluR-B-RNA-specific editing activity, indicating that either the putative factor(s) itself can bind tightly to dsRNA, or that it interacts with dsRAD to enhance its affinity for dsRNA.
Proof that additional factors are required for editing gluR RNA in vivo will require further studies with more purified systems. However, if one accepts that there are factors that act in concert with dsRAD in vivo, two possible roles for these factors can be envisioned. First, endogenous accessory factors could alter the deamination specificity of dsRAD. As the editing sites that have been mapped within gluR RNAs are entirely consistent with the deamination specificity that is intrinsic to dsRAD [13] , at its extreme this hypothesis seems unlikely. The second hypothesis assumes that the specificity intrinsic to dsRAD operates in vivo in much the same way that it does in vitro. In this case, however, requisite accessory factors would act as chaperones to help dsRAD substrates assume the structure that allows the intrinsic specificity of dsRAD to produce the editing events observed in vivo. If the latter scenario holds true, it may be possible to find in vitro conditions that promote the correct structure of gluR RNAs so that dsRAD could act alone.
Regardless, it is certainly an interesting time for studies of both gluR RNA editing and dsRAD. The enzyme dsRAD has now been purified from several organisms, and several mammalian cDNAs have been cloned [14, 15] . These reagents should facilitate the identification of the putative accessory factors required for gluR RNA editing, as well as more in-depth studies of the role of editing in modulating gluR function. Laboratories long involved in studies of dsRAD using synthetic substrates will no doubt gain additional insight by characterizing the enzymes using biological substrates.
So far, editing of metazoan RNAs has only been observed in mammals. The enzyme dsRAD is widespread among metazoans, suggesting that other examples of editing in metazoans exist. In addition, as pointed out by Melcher et al. [9] , dsRAD is present in mammalian cells that do not express gluR genes, suggesting that other dsRAD substrates exist in mammals. Finally, an obvious question is whether dsRAD is primarily an RNA-editing enzyme or has another, as yet undetermined, biological function. Given the multiple editing sites mapped within gluR RNAs that have no obvious function (see Fig. 1 ), it seems likely that dsRAD was coopted as an editing enzyme from another aspect of RNA metabolism. Until further notice, it seems prudent for scientists studying nuclear encoded RNAs to adopt the cautious approach in regard to cDNA sequences long held by those studying organelle-encoded RNAs.
